<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0189491</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-32970</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Complementary and alternative medicine</subject><subj-group><subject>Traditional medicine</subject><subj-group><subject>Traditional Chinese medicine</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Irritable bowel syndrome</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Irritable bowel syndrome</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Abdominal pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Abdominal pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Defecation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Defecation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Gastrointestinal motility disorders</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Clinical research design</subject><subj-group><subject>Adverse events</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome</article-title>
<alt-title alt-title-type="running-head">Meta-analysis of traditional Chinese medicine in the treatment of IBS-C</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Dan-yan</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1667-4670</contrib-id>
<name name-style="western">
<surname>Dai</surname>
<given-names>Yun-kai</given-names>
</name>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Yun-zhan</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>Meng-xin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Ru-liu</given-names>
</name>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ou-yang</surname>
<given-names>Jia</given-names>
</name>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Wei-jing</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3104-8050</contrib-id>
<name name-style="western">
<surname>Hu</surname>
<given-names>Ling</given-names>
</name>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Institute of Gastroenterology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Neurosurgery, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Green</surname>
<given-names>John</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University Hospital Llandough, UNITED KINGDOM</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">drhuling@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>12</issue>
<elocation-id>e0189491</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Li et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0189491"/>
<abstract>
<sec id="sec001">
<title>Aim</title>
<p>This meta-analysis analyzed the efficacy and safety of traditional Chinese medicine (TCM) for the treatment of irritable bowel syndrome with constipation (IBS-C).</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>We searched seven electronic databases for randomized controlled trials investigating the efficacy of TCM in the treatment of IBS-C. The search period was from inception to June 1, 2017. Eligible RCTs compared TCM with cisapride and mosapride. Article quality was evaluated with the Cochrane Risk Bias Tool in the Cochrane Handbook by two independent reviewers. Begg’s test was performed to evaluate publication bias. Review Manager 5.3 and Stata 12.0 were used for analyses.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Eleven eligible studies comprising a total of 906 participants were identified. In the primary outcome, TCM showed significant improvement in overall clinical efficacy compared with cisapride and mosapride (odds ratio [OR] = 4.00; 95% confidence interval [CI]: 2.74,5.84; P &lt; 0.00001). In terms of secondary outcomes, TCM significantly alleviated abdominal pain (OR = 5.69; 95% CI: 2.35, 13.78; P = 0.0001), defecation frequency (OR = 4.38; 95% CI: 1.93, 9.93. P = 0.0004), and stool form (OR = 4.96; 95% CI: 2.11, 11.65; P = 0.0002) in the treatment group as compared to the control group. A lower recurrence rate was associated with TCM as compared to cisapride and mosapride (OR = 0.15; 95% CI: 0.08, 0.27; P &lt; 0.00001). No adverse effects were observed during TCM treatment.</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>TCM showed greater improvement in terms of clinical efficacy in the treatment of IBS-C than cisapride and mosapride, although it was not possible to draw a definitive conclusion due to the small sample size, high risk, and low quality of the studies. Large multi-center and long-term high-quality randomized control trials are needed.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>No.81373563</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3104-8050</contrib-id>
<name name-style="western">
<surname>Hu</surname>
<given-names>Ling</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Innovation team to foster scientific research projects of Guangzhou University of Chinese Medicine</institution>
</funding-source>
<award-id>No.2016KYTD07</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3104-8050</contrib-id>
<name name-style="western">
<surname>Hu</surname>
<given-names>Ling</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution>Construction of high-level university of Guangzhou University of Chinese Medicine</institution>
</funding-source>
<award-id>N0.64</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3104-8050</contrib-id>
<name name-style="western">
<surname>Hu</surname>
<given-names>Ling</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>No.81774238</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3104-8050</contrib-id>
<name name-style="western">
<surname>Hu</surname>
<given-names>Ling</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This research was supported by National Natural Science Foundation of China, No.81373563; Innovation team to foster scientific research projects of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No.7, No.2016KYTD07; Construction of high-level university of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No.64; National Natural Science Foundation of China, No.81774238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="8"/>
<table-count count="3"/>
<page-count count="14"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>1. Introduction</title>
<p>Irritable bowel syndrome (IBS) is one of the most common functional bowel disorders, which is characterized by recurrent abdominal pain or discomfort with accompanying disturbances in defecation that cannot be attributed to any demonstrable biochemical, structural, or anatomical abnormality [<xref ref-type="bibr" rid="pone.0189491.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0189491.ref002">2</xref>]. Thus, the diagnosis of IBS is based on symptoms, according to which the disorder is classified as IBS-C (IBS with pain or discomfort and predominant constipation), IBS-D (IBS with diarrhea), IBS-M (mixed IBS), or IBS-U (unsubtyped) [<xref ref-type="bibr" rid="pone.0189491.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0189491.ref004">4</xref>]. Epidemiologic studies have reported a high prevalence of IBS ranging from 5%–22% in various countries [<xref ref-type="bibr" rid="pone.0189491.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0189491.ref006">6</xref>], 2.9%–15.6% in Asian countries [<xref ref-type="bibr" rid="pone.0189491.ref007">7</xref>], and 0.82%–11.5% in China [<xref ref-type="bibr" rid="pone.0189491.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0189491.ref009">9</xref>]. Although IBS causes no physical injury to patients, it reduces their quality of life and consumes a significant amount of medical resources due to its chronicity and frequency of symptoms [<xref ref-type="bibr" rid="pone.0189491.ref010">10</xref>].</p>
<p>Drugs that promote gastrointestinal motility are the main treatment for IBS-C; for example, the 5-hydroxytryptamine (serotonin; 5-HT) agonists cisapride and mosapride provide effective relief of the predominant symptoms. However, long-term use of these drugs is associated with a risk of cardiovascular events [<xref ref-type="bibr" rid="pone.0189491.ref011">11</xref>]. Many IBS patients seek alternative treatments such as traditional Chinese medicine (TCM) [<xref ref-type="bibr" rid="pone.0189491.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0189491.ref014">14</xref>], in which treatment is based on syndrome differentiation. TCM represent one aspect of Chinese medical philosophy that is characterized by its emphasis on maintaining and restoring balance[<xref ref-type="bibr" rid="pone.0189491.ref015">15</xref>].</p>
<p>A series of systematic reviews evaluating the effectiveness of TCM for treating IBS-D treatment have been published [<xref ref-type="bibr" rid="pone.0189491.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0189491.ref020">20</xref>]. However, there is little information on the efficacy of TCM for the treatment of IBS-C. To address this issue, we carried out a meta-analysis to evaluate the safety and efficacy of TCM for IBS-C treatment.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>2. Methods</title>
<sec id="sec007">
<title>2.1. Data sources and search strategy</title>
<p>Seven electronic databases including PubMed, Springer, EMBASE, CNKI(China National Knowledge Infrastructure), CBM (Chinese Biomedicine Database), WanFang, and VIP (Chinese Scientific Journals Database) were searched for randomized controlled trials (RCTs) evaluating the effects of TCM and gastrointestinal motility drugs on the clinical outcome of IBS-C. The search period was from inception to June 1, 2017. The following key words were used for our search: “Traditional Chinese medicine”, “irritable bowel syndrome”, “IBS”, “Constipation Type of Irritable Bowel Syndrome”, “IBS-C”, “clinical research”, and “clinical trial”.</p>
</sec>
<sec id="sec008">
<title>2.2. Selection criteria</title>
<p>Two reviewers (D.-Y.L. and Y.-K.D.) independently reviewed the full-text versions of all the articles retrieved in the literature search to identify eligible studies. Conflicts in study selection were resolved by a third reviewer (J.-O.Y). Inclusion criteria were as follows: (1) IBS-C was definitively diagnosed according to Rome II[<xref ref-type="bibr" rid="pone.0189491.ref021">21</xref>], III[<xref ref-type="bibr" rid="pone.0189491.ref022">22</xref>], or IV criteria[<xref ref-type="bibr" rid="pone.0189491.ref023">23</xref>]; (2) clinical trial; (3) treatment groups used only traditional Chinese medicine (decoction, granules, capsule or tablet), while control groups used mosapride or cisapride (capsule or tablet); (4) randomized controlled trial (RCT); (5) duration of the treatment was at least 4 weeks for all groups; and (6) published in any language. Exclusion criteria were as follows: (1) not IBS-C; (2) IBS-D, IBS-M, IBS-U; (3) duplicate publication; (4) included subjects with severe enteric disease or who developed a malignancy, heart failure, or renal failure during the study period, and (5) publication was a commentary, editorial, reviews or case report.</p>
</sec>
<sec id="sec009">
<title>2.3 Efficacy evaluation index</title>
<p>The indicator of primary outcome was overall clinical efficacy; secondary outcome indicators were symptom improvement rate, recurrence rate, and adverse reaction. According to the TCM Illness Diagnosis Affect Standard and Guidance Principle of Clinical Study on New Drug of Traditional Chinese Medicine [<xref ref-type="bibr" rid="pone.0189491.ref024">24</xref>, <xref ref-type="bibr" rid="pone.0189491.ref025">25</xref>], efficacy evaluation was divided into four grades: cured, markedly effective, effective, and ineffective. The nimodipine method [<xref ref-type="bibr" rid="pone.0189491.ref024">24</xref>] was used to assess changes in the efficacy index, which was calculated with the formula [(pre-treatment symptom score − symptom score after treatment / pre-treatment symptom score)] × 100%.</p>
</sec>
<sec id="sec010">
<title>2.4 Literature quality evaluation</title>
<p>The Cochrane Risk Bias Tool in the Cochrane Handbook for Systematic Reviews of Interventions was used to assess the quality of included studies, which supplemented by Jadad score[<xref ref-type="bibr" rid="pone.0189491.ref026">26</xref>]. Evaluation of methodological quality was also assessed by two independent reviewers, and a third reviewer was consulted when there were discrepancies.</p>
</sec>
<sec id="sec011">
<title>2.5. Data extraction</title>
<p>Two reviewers (D.-Y.L. and Y.-K.D.) used a standardized data extraction form to independently extract data from studies that met the inclusion criteria, including (1) general information, including name of the first author, publication year, sample size, age, disease duration, trial duration, and intervention; (2) details of the study design, including descriptions of randomization methods, blinding, allocation concealment, and bias prevention; (3) clinical outcomes at the end of the treatment, number of withdrawals or dropouts, and follow-up periods; and (4) adverse events during treatment. Extracted data were cross-checked by the two reviewers. In cases of uncertainty about eligibility, a third reviewer was consulted.</p>
</sec>
<sec id="sec012">
<title>2.6. Statistical analysis</title>
<p>Outcomes for which data could not be compared directly across studies were synthesized qualitatively, as were outcomes for which insufficient data were reported across studies. Outcomes for which sufficient, equivalent data were reported across studies were meta -analyzed using Forest plots generated with RevMan 5.3[<xref ref-type="bibr" rid="pone.0189491.ref027">27</xref>]. Enumerated data were analyzed using OR or relative risk (RR) and 95% CI. The χ<sup>2</sup> test and the inconsistency index statistic (I<sup>2</sup>) for heterogeneity were conducted [<xref ref-type="bibr" rid="pone.0189491.ref028">28</xref>]. If substantial heterogeneity existed (I<sup>2</sup>&gt; 50% or P&lt; 0.05), a random effect model was applied. If there was no observed heterogeneity, fixed effect models were chosen [<xref ref-type="bibr" rid="pone.0189491.ref029">29</xref>]. A sensitivity analysis was done to explore potential sources of heterogeneity. Begg’s test was performed to evaluate publication bias [<xref ref-type="bibr" rid="pone.0189491.ref030">30</xref>]. Review Manager 5.3 and Stata 12.0 were used for analyses.</p>
</sec>
</sec>
<sec id="sec013" sec-type="results">
<title>3. Results</title>
<sec id="sec014">
<title>3.1 Study description</title>
<p>The literature search identified 1062 studies. The detailed screening process is shown in <xref ref-type="fig" rid="pone.0189491.g001">Fig 1</xref>(<bold><xref ref-type="fig" rid="pone.0189491.g001">Fig 1</xref></bold> Flow diagram of literature search). Based on the inclusion and exclusion criteria, 11 RCTs [<xref ref-type="bibr" rid="pone.0189491.ref031">31</xref>–<xref ref-type="bibr" rid="pone.0189491.ref041">41</xref>] were ultimately included in the meta-analysis, comprising 906 participants (494 in the trial group and 412 in the control group) ranging in age from 17 to 72 years old; in two studies [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] the participants’ ages were not mentioned. Disease duration was between 3 months and 12 years; three articles [<xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0189491.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0189491.ref038">38</xref>] did not mention the duration. The course of treatment was between 4 and 8 weeks. Ten of the treatment groups used a Chinese medicine decoction which refers to the liquid formulation that is obtained by boiling pieces or coarse grains of herbs in water or soaking the crude medicine in boiling water followed by filtration [<xref ref-type="bibr" rid="pone.0189491.ref042">42</xref>].while one used granules [<xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>]. In the control group, four articles used cisapride [<xref ref-type="bibr" rid="pone.0189491.ref031">31</xref>–<xref ref-type="bibr" rid="pone.0189491.ref034">34</xref>] and seven articles used mosapride [<xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>–<xref ref-type="bibr" rid="pone.0189491.ref041">41</xref>]. All selected RCTs reported overall clinical efficacy at the end of the treatment, and three [<xref ref-type="bibr" rid="pone.0189491.ref031">31</xref>–<xref ref-type="bibr" rid="pone.0189491.ref033">33</xref>] reported recurrence rate and follow-up periods. The characteristics of the studies are listed in <xref ref-type="table" rid="pone.0189491.t001">Table 1</xref>.</p>
<fig id="pone.0189491.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram of literature search.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0189491.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of the studies included in the meta-analysis.</title></caption>
<alternatives>
<graphic id="pone.0189491.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2"><break/>First Author, Year</th>
<th align="center" rowspan="2">Country</th>
<th align="center" rowspan="2">Diagnostic Criteria</th>
<th align="center"><break/>N</th>
<th align="center" rowspan="2">Age<break/>(years)</th>
<th align="center" colspan="3">Disease duration (years)</th>
<th align="center" rowspan="2">Duration<break/>(weeks)</th>
<th align="center" colspan="2">Intervention</th>
<th align="center" rowspan="2">Follow-up</th>
<th align="center" rowspan="2">Recurrence rate</th>
</tr>
<tr>
<th align="center">(T vs. C)</th>
<th align="center">T</th>
<th align="center" colspan="2">C</th>
<th align="center">T</th>
<th align="center">C</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Cai 2005 (31)</td>
<td align="center">China</td>
<td align="center">Rome II</td>
<td align="center">60 vs. 30</td>
<td align="center">19–72</td>
<td align="center">0.25–17</td>
<td align="center" colspan="2">0.42–6.5</td>
<td align="center">4</td>
<td align="left">Decoction of liver -soothing and stomach -regulating, 200mL, b.i.d</td>
<td align="left">Cisapride tablets, 5mg, tid</td>
<td align="center">6m</td>
<td align="center">mentioned</td>
</tr>
<tr>
<td align="center">Chen 2005 (32)</td>
<td align="center">China</td>
<td align="center">Rome II</td>
<td align="center">41 vs. 37</td>
<td align="center">Not mentioned</td>
<td align="center">1.55±0.45</td>
<td align="center" colspan="2">1.49±0.51</td>
<td align="center">4</td>
<td align="left">Yiji II recipe, t.i.d</td>
<td align="left">Cisapride tablets, 5mg, tid</td>
<td align="center">4w</td>
<td align="center">mentioned</td>
</tr>
<tr>
<td align="center">Wu 2006 (33)</td>
<td align="center">China</td>
<td align="center">Rome II</td>
<td align="center">85 vs. 85</td>
<td align="center">26–70</td>
<td align="center">1–10</td>
<td align="center" colspan="2">1–9.5</td>
<td align="center">8</td>
<td align="left">Decoction of Buqi Jianpi, 150mL, b.i.d</td>
<td align="left">Cisapride tablets, 5mg, tid</td>
<td align="center">4w</td>
<td align="center">mentioned</td>
</tr>
<tr>
<td align="center">Wang 2008 (34)</td>
<td align="center">China</td>
<td align="center">Rome II</td>
<td align="center">50 vs. 33</td>
<td align="center">20–65</td>
<td align="center">4.9±1.54</td>
<td align="center" colspan="2">4.5±1.84</td>
<td align="center">4</td>
<td align="left">Yangxue Tongfu Decoction, 300mL,b.i.d</td>
<td align="left">Cisapride tablets, 5mg, tid</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
<tr>
<td align="center">Li 2011<break/>(35)</td>
<td align="center">China</td>
<td align="center">Rome III</td>
<td align="center">50 vs. 35</td>
<td align="center">48.01±6.70</td>
<td align="center" colspan="3">3.26±1.33</td>
<td align="center">4</td>
<td align="left">Compound granules with Regulating Qi and Moistening the Intestine -s, 100mL, b.i.d</td>
<td align="left">Mosapride citrate tablets, 5mg, t.i.d</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
<tr>
<td align="center">Liao 2011 (36)</td>
<td align="center">China</td>
<td align="center">Rome III</td>
<td align="center">35 vs. 20</td>
<td align="center">T:51.7±12.9<break/>C:52.6±12.9</td>
<td align="center" colspan="2">N.R</td>
<td align="center">N.R</td>
<td align="center">4</td>
<td align="left">Modified Sini Powder and Liumo Decoction, b.i.d</td>
<td align="left">Mosapride citrate tablets, 5mg, t.i.d</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
<tr>
<td align="center">Qian 2011 (37)</td>
<td align="center">China</td>
<td align="center">Rome III</td>
<td align="center">25 vs. 25</td>
<td align="center">21–61</td>
<td align="center" colspan="2">2.51±1.23</td>
<td align="center">2.8±1.18</td>
<td align="center">4</td>
<td align="left">Modified Fluid-increasing Decoction, b.i.d</td>
<td align="left">Mosapride citr -ate tablets, 5mg, t.i.d</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
<tr>
<td align="center">Chen 2013 (38)</td>
<td align="center">China</td>
<td align="center">Rome III</td>
<td align="center">20 vs. 20</td>
<td align="center">T:41.89±5.67 C:40.31±6.98</td>
<td align="center" colspan="2">N.R</td>
<td align="center">N.R</td>
<td align="center">4</td>
<td align="left">Decoction of Replenishing Qi to invigorate the Spleen and ventilating the Lung,200mL, b.i.d</td>
<td align="left">Mosapride tablets, 5mg, t.i.d</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
<tr>
<td align="center">Zhang 2014 (39)</td>
<td align="center">China</td>
<td align="center">Rome III</td>
<td align="center">48 vs. 48</td>
<td align="center">22–64</td>
<td align="center" colspan="2">1–13</td>
<td align="center">1–12</td>
<td align="center">4</td>
<td align="left">Modified Guipi Decoction and Xiaoyao Powder, b.i.d</td>
<td align="left">Mosapride capsules, 5mg, t.i.d</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
<tr>
<td align="center">Wang 2015 (40)</td>
<td align="center">China</td>
<td align="center">Rome III</td>
<td align="center">40 vs. 39</td>
<td align="center">Not mentioned</td>
<td align="center" colspan="2">0.25–11</td>
<td align="center">0.5–12</td>
<td align="center">8</td>
<td align="left">Modified Sanzang Tiaohe Runchang Decoction, 150 mL, b.i.d</td>
<td align="left">Mosapride citrate tablets, 5mg, t.i.d</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
<tr>
<td align="center">Zhang 2016 (41)</td>
<td align="center">China</td>
<td align="center">Rome III</td>
<td align="center">40 vs. 40</td>
<td align="center">21–68</td>
<td align="center" colspan="2">4.3±1.2</td>
<td align="center">4.5±1.5</td>
<td align="center">4</td>
<td align="left">Treatment base on TCM Syndrome Differentiation, b.i.d</td>
<td align="left">Mosapride citrate tablets, 5mg, t.i.d</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>N.R = not reported; T = Treatment group; C = control group; b.i.d = bisindie; t.i.d = terindie;VS. = Versus.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>3.2 Methodological quality</title>
<p>All included studies were randomized studies with comparable baselines. Two studies [<xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>] used random number tables: one [<xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] according to the principle of minimum distribution of unbalanced index, and one [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>] as a simple random table. The remaining seven studies did not mention a specific method. Ten studies did not mention double blinding or allocation concealment; only one [<xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>] mentioned the use of sealed envelopes although a non-blinded approach was adopted. One trial [<xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] reported patient dropout, but an Intention-to-Treat (ITT) analysis was not performed. For other types of bias, seven studies [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>–<xref ref-type="bibr" rid="pone.0189491.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>–<xref ref-type="bibr" rid="pone.0189491.ref041">41</xref>] were rated as unclear risk due to the lack of information on age, disease duration, and dosage of Chinese medicine. This meta-analysis was considered as having a high risk of bias (<xref ref-type="fig" rid="pone.0189491.g002">Fig 2</xref> Methodological quality assessment of the risk of bias).A description of the evaluation of methodological quality of the 11 trials can be found in <xref ref-type="table" rid="pone.0189491.t002">Table 2</xref>.</p>
<fig id="pone.0189491.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Methodological quality assessment of the risk of bias.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g002" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0189491.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.t002</object-id>
<label>Table 2</label> <caption><title>Evaluation of methodological quality of the included studies.</title></caption>
<alternatives>
<graphic id="pone.0189491.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Study ID</th>
<th align="center">Baseline</th>
<th align="center">Randomization</th>
<th align="center">Double<break/>Blinding</th>
<th align="center">Withdrawal<break/>or dropout</th>
<th align="center">Allocation<break/>concealment</th>
<th align="center">Side<break/>effects</th>
<th align="center">Jadad<break/>scores</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Cai 2005 (31)</td>
<td align="center">Comparability</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Chen2005 (32)</td>
<td align="center">Comparability</td>
<td align="center">Simple random table</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">C:6 cases</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Wu 2006 (33)</td>
<td align="center">Comparability</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">No</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Wang2008(34)</td>
<td align="center">Comparability</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Li 2011(35)</td>
<td align="center">Comparability</td>
<td align="center">Random number table</td>
<td align="center">Unblinded</td>
<td align="center">N.R</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">2</td>
</tr>
<tr>
<td align="center">Liao 2011 (36)</td>
<td align="center">Comparability</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Qian 2011 (37)</td>
<td align="center">Comparability</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">No</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Chen 2013(38)</td>
<td align="center">Comparability</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Zhang2014(39)</td>
<td align="center">Comparability</td>
<td align="center">Random number table</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">2</td>
</tr>
<tr>
<td align="center">Wang 2015(40)</td>
<td align="center">Comparability</td>
<td align="center">The principle of minimum distribution of unbalanced index</td>
<td align="center">N.R</td>
<td align="center">C:1 case</td>
<td align="center">N.R</td>
<td align="center">C:1 case</td>
<td align="center">3</td>
</tr>
<tr>
<td align="center">Zhang2016 (41)</td>
<td align="center">Comparability</td>
<td align="center">Mentioned not described</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">N.R</td>
<td align="center">1</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>N.R = not reported; C = control group.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec016">
<title>3.3 Primary outcome: Overall clinical efficacy</title>
<p>Overall clinical efficacy was evaluated in 11 trials. The study included 906 patients; 494 were assigned to treatment groups, whereas 412 were assigned to control groups. TCM significantly improved overall clinical efficacy as compared to cisapride and mosapride (OR = 4.00; 95% CI: 2.74, 5.84; P &lt; 0.00001) (<xref ref-type="fig" rid="pone.0189491.g003">Fig 3</xref> Forest plot of primary outcomes (fixed effect model). No heterogeneity was observed (χ<sup>2</sup> = 7.52, P = 0.68, I<sup>2</sup> = 0%). Funnel plot analysis demonstrated evidence of publication bias (Begg’s test, P = 0.013) (<xref ref-type="fig" rid="pone.0189491.g004">Fig 4</xref> Begg’s funnel plot analysis of primary outcomes).</p>
<fig id="pone.0189491.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plot of primary outcomes (fixed effect model).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g003" xlink:type="simple"/>
</fig>
<fig id="pone.0189491.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Begg’s funnel plot analysis of primary outcomes.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>3.4 Secondary outcomes</title>
<sec id="sec018">
<title>Abdominal pain</title>
<p>Five of the 11 studies [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0189491.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] reported the outcome of abdominal pain improvement; three of these [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0189491.ref036">36</xref>] used symptom scores, although the scoring criteria were inconsistent. The remaining two studies [<xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>], in which evaluation was based on efficacy, were incorporated into the meta-analysis. TCM resulted in greater abdominal pain alleviation relative to controls (OR = 5.69; 95% CI: 2.35, 13.78; P = 0.0001), with no statistical heterogeneity (χ<sup>2</sup> = 0.05, P = 0.82, I<sup>2</sup> = 0%) (<xref ref-type="fig" rid="pone.0189491.g005">Fig 5</xref> Forest plot of improvements in abdominal pain (fixed effects model)).</p>
<fig id="pone.0189491.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Forest plot of improvements in abdominal pain (fixed effects model).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec019">
<title>Defecation frequency</title>
<p>Three studies [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] reported an alleviation in defecation frequency. One [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>] used symptom scores to assess the alleviation whereas the other two [<xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] evaluated the efficacy and were therefore included in our analysis. TCM significantly alleviated defecation frequency as compared to control groups (OR = 4.38; 95% CI: 1.93, 9.93. P = 0.0004). There was no apparent heterogeneity (χ<sup>2</sup> = 0.99, P = 0.32, I<sup>2</sup> = 0%) (<xref ref-type="fig" rid="pone.0189491.g006">Fig 6</xref> Forest plot of the improvement in defecation frequency (fixed effects model)).</p>
<fig id="pone.0189491.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Forest plot of the improvement in defecation frequency (fixed effects model).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g006" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec020">
<title>Stool form</title>
<p>Four studies [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0189491.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] reported an alleviation in stool form according to symptoms. Two [<xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] used the same criteria and were included in the analysis. TCM alleviated stool form relative to the control group (OR = 4.96; 95% CI: 2.11, 11.65; P = 0.0002); there was no heterogeneity observed (χ<sup>2</sup> = 0.02, P = 0.89, I<sup>2</sup> = 0%) (<xref ref-type="fig" rid="pone.0189491.g007">Fig 7</xref> Forest plot of the improvement in stool form (fixed effects model)). There were limited descriptions in the literature of other symptoms such as abnormal bowel movements, abdominal tenderness [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>], incomplete evacuation, fatigue [<xref ref-type="bibr" rid="pone.0189491.ref036">36</xref>] or anorexia [<xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>]; this information was therefore only useful for a qualitative analysis.</p>
<fig id="pone.0189491.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Forest plot of the improvement in stool form (fixed effects model).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g007" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec021">
<title>3.5 Recurrence rate and adverse events</title>
<p>Among included studies, three trials [<xref ref-type="bibr" rid="pone.0189491.ref031">31</xref>–<xref ref-type="bibr" rid="pone.0189491.ref033">33</xref>] reported recurrence rate during a 6-month follow-up after the treatment course. The fixed-effects model showed that TCM had a significantly lower recurrence rate than cisapride and mosapride (OR = 0.15; 95% CI: 0.08, 0.27; P &lt; 0.00001). There was no observed heterogeneity (I<sup>2</sup> = 0%, P = 0.57) (<xref ref-type="fig" rid="pone.0189491.g008">Fig 8</xref> Forest plot of recurrence rate (fixed effects model)). Summary of meta-analysis outcomes can be found in <xref ref-type="table" rid="pone.0189491.t003">Table 3</xref>.</p>
<fig id="pone.0189491.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.g008</object-id>
<label>Fig 8</label>
<caption>
<title>Forest plot of recurrence rate (fixed effects model).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.g008" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0189491.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189491.t003</object-id>
<label>Table 3</label> <caption><title>Summary of meta-analysis outcomes.</title></caption>
<alternatives>
<graphic id="pone.0189491.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">Outcomes</th>
<th align="center" rowspan="2">N</th>
<th align="center" rowspan="2">Patients<break/>(T/C)</th>
<th align="center" colspan="2">Overall effect</th>
<th align="center" colspan="2">Heterogeneity</th>
</tr>
<tr>
<th align="center">OR (95% CI)</th>
<th align="center">P</th>
<th align="center">I<sup>2</sup></th>
<th align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="7">Primary outcome</td>
</tr>
<tr>
<td align="center">Overall clinical efficacy</td>
<td align="center">11</td>
<td align="center">494/412</td>
<td align="center">4.00[2.74,5.84]</td>
<td align="center">&lt;0.0001</td>
<td align="center">7.52</td>
<td align="center">0.68</td>
</tr>
<tr>
<td align="left" colspan="7">Secondary outcomes</td>
</tr>
<tr>
<td align="left">    Abdominal pain</td>
<td align="center">2</td>
<td align="center">81/79</td>
<td align="center">5.69[2.35,13.78]</td>
<td align="center">0.0001</td>
<td align="center">0.05</td>
<td align="center">0.82</td>
</tr>
<tr>
<td align="left">    Defecation frequency</td>
<td align="center">2</td>
<td align="center">82/85</td>
<td align="center">4.38[1.93,9.93]</td>
<td align="center">0.0004</td>
<td align="center">0.99</td>
<td align="center">0.32</td>
</tr>
<tr>
<td align="left">    Stool form</td>
<td align="center">2</td>
<td align="center">87/87</td>
<td align="center">4.96[1.37,20.78]</td>
<td align="center">0.0002</td>
<td align="center">0.02</td>
<td align="center">0.89</td>
</tr>
<tr>
<td align="left">    Recurrence rate</td>
<td align="center">3</td>
<td align="center">161/110</td>
<td align="center">0.15[0.08,0.27]</td>
<td align="center">&lt;0.0001</td>
<td align="center">1.13</td>
<td align="center">0.57</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>N: number of studies; OR: odds ratio; CI:confidence interval; T = Treatment group; C = control group.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Two studies [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>] mentioned adverse events in the control group. One patient withdrew from the study after reporting dizziness and dry mouth [<xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>], and two cases of low abdominal pain, three cases of mild diarrhea, and one case of bowel movements were also reported [<xref ref-type="bibr" rid="pone.0189491.ref032">32</xref>]. No adverse effects were observed during TCM treatment.</p>
</sec>
</sec>
<sec id="sec022" sec-type="conclusions">
<title>Discussion</title>
<p>This meta-analysis investigated the efficacy of TCM in the treatment of IBS-C as compared to gastrointestinal motility drugs. The results showed that TCM produced greater alleviation in IBS-C symptoms than cisapride and mosapride. Data from only two trials were included in the analysis of secondary outcomes, and the analysis showed that TCM alleviated abdominal pain (OR = 5.69), defecation frequency (OR = 4.38) and stool form (OR = 4.96) as compared to the control group. Furthermore, patients treated with TCM had a significantly lower recurrence rate than controls (OR = 0.15), with no adverse events. For instance, in one study [<xref ref-type="bibr" rid="pone.0189491.ref035">35</xref>] patients were aware of which treatment they received, whereas another study [<xref ref-type="bibr" rid="pone.0189491.ref031">31</xref>] excluded one patient due to adverse effects but an ITT analysis was not performed, potentially leading to incomplete outcome data. Therefore, although TCM appears to be superior to gastrointestinal motility drugs for the treatment of IBS-C, the efficacy of traditional Chinese medicine requires further study.</p>
<p>The pathophysiology of IBS is not fully understood; it is thought to involve many factors, including gastrointestinal dysmotility [<xref ref-type="bibr" rid="pone.0189491.ref043">43</xref>], visceral hypersensitivity [<xref ref-type="bibr" rid="pone.0189491.ref044">44</xref>, <xref ref-type="bibr" rid="pone.0189491.ref045">45</xref>], intestinal mucosa activation [<xref ref-type="bibr" rid="pone.0189491.ref004">4</xref>], increased intestinal permeability [<xref ref-type="bibr" rid="pone.0189491.ref046">46</xref>], inflammation, epigenetics, and genetics [<xref ref-type="bibr" rid="pone.0189491.ref047">47</xref>]. Many studies have reported that TCM is effective for IBS-C treatment. Ma Zhi Jiang Zhuo was shown to relieve constipation symptoms in a rat model of IBS-C, possibly by increasing the rate of small intestine propulsion and reducing 5-HT level in the colon [<xref ref-type="bibr" rid="pone.0189491.ref048">48</xref>]. Maziren pills increased visceral hypersensitivity by decreasing 5-HT levels in IBS-C rats [<xref ref-type="bibr" rid="pone.0189491.ref049">49</xref>]. Clinical trials have shown that flavored Maren pills improved abdominal symptoms and constipation in IBS-C by modulating the balance between pro- and anti-inflammatory cytokines—i.e., by decreasing interleukin (IL)-6 and increasing IL-10 levels [<xref ref-type="bibr" rid="pone.0189491.ref050">50</xref>]. On the other hand, clinical data have shown that liver-discharging, qi-regulating, and intestine-moistening therapies can relieve abdominal pain and improve constipation symptoms, possibly by reducing plasma vasoactive intestinal peptide (VIP) and somatostatin (SS) levels [<xref ref-type="bibr" rid="pone.0189491.ref051">51</xref>]. Kuanzhongjieyutang can improve IBS symptoms and patients’ quality of life by reducing plasma levels of VIP, SS, and 5-HT and modulating the brain-gut axis, thereby decreasing visceral hypersensitivity and improving intestinal motor function [<xref ref-type="bibr" rid="pone.0189491.ref052">52</xref>]. Ballast capsules can improve IBS symptoms by increasing motilin and decreasing endothelin levels [<xref ref-type="bibr" rid="pone.0189491.ref053">53</xref>]. Additional studies of these herbal formulae are needed in order to clarify the mechanisms underlying these effects.</p>
<p>There were several limitations to this meta-analysis. First, the course of treatment was between 4 and 8 weeks, and three trials [<xref ref-type="bibr" rid="pone.0189491.ref031">31</xref>–<xref ref-type="bibr" rid="pone.0189491.ref033">33</xref>] reported a 6-month follow-up, which was not sufficiently long to evaluate the long-term efficacy of TCM for IBS-C in all included studies. Second, only three studies [<xref ref-type="bibr" rid="pone.0189491.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0189491.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>] reported safety evaluation. In one, routine blood, urine, and stool tests were performed and liver and kidney function were evaluated before and after treatment [<xref ref-type="bibr" rid="pone.0189491.ref033">33</xref>]. In the other two studies, enteroscopy [<xref ref-type="bibr" rid="pone.0189491.ref037">37</xref>] and electrocardiography [<xref ref-type="bibr" rid="pone.0189491.ref039">39</xref>] were performed in addition to these tests. Results from all of the tests were normal. The safety of TCM must be confirmed in future studies. Third, although the results showed that disease recurrence rate in patients treated by TCM was relatively low, this may be unreliable due to the limited number of studies that were suitable for analysis [<xref ref-type="bibr" rid="pone.0189491.ref031">31</xref>–<xref ref-type="bibr" rid="pone.0189491.ref033">33</xref>]. Fourth, dropouts were reported in one study [<xref ref-type="bibr" rid="pone.0189491.ref040">40</xref>], but ITT analysis was not performed, which could lead to bias in evaluating the clinical efficacy of the intervention. Finally, our meta-analysis included published studies that were conducted in China and published in Chinese, only, and some of the unpublished data were not available for various reasons. In general, the studies had a high risk of bias and low methodological quality. Whether the effect size of TCM would be similar in large-scale trials remains to be determined.</p>
</sec>
<sec id="sec023" sec-type="conclusions">
<title>Conclusions</title>
<p>IBM-C patients treated with TCM showed greater improvement than those treated with cisapride or mosapride. However, it is difficult to draw definitive conclusions from our meta-analysis due to the small sample size, high heterogeneity, and low quality of the included studies. Large, multi-center, long-term, and high-quality RCTs are needed to confirm whether TCM is a viable alternative to conventional drugs for the treatment of IBS-C.</p>
</sec>
<sec id="sec024">
<title>Supporting information</title>
<supplementary-material id="pone.0189491.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.s001" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>A sample search strategy.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0189491.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0189491.s002" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>This research was supported by National Natural Science Foundation of China, No.81373563; Innovation team to foster scientific research projects of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No.7, No.2016KYTD07; Construction of high-level university of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No.64; National Natural Science Foundation of China, No.81774238.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0189491.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Talley</surname> <given-names>NJ</given-names></name>. <article-title>Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment</article-title>. <source>Trends in pharmacological sciences</source>. <year>2010</year>; <volume>31</volume>:<fpage>326</fpage>–<lpage>334</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tips.2010.04.008" xlink:type="simple">10.1016/j.tips.2010.04.008</ext-link></comment> <object-id pub-id-type="pmid">20554042</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Longstreth</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>WG</given-names></name>, <name name-style="western"><surname>Chey</surname> <given-names>WD</given-names></name>, <name name-style="western"><surname>Houghton</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Mearin</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Spiller</surname> <given-names>RC</given-names></name>. <article-title>Functional bowel disorders</article-title>. <source>Gastroenterology</source>. <year>2006</year>; <volume>130</volume>:<fpage>1480</fpage>–<lpage>1491</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2005.11.061" xlink:type="simple">10.1053/j.gastro.2005.11.061</ext-link></comment> <object-id pub-id-type="pmid">16678561</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krogius-Kurikka</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lyra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Malinen</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Aarnikunnas</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tuimala</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Paulin</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers</article-title>. <source>BMC gastroenterology</source>. <year>2009</year>; <volume>9</volume>:<fpage>95</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-230X-9-95" xlink:type="simple">10.1186/1471-230X-9-95</ext-link></comment> <object-id pub-id-type="pmid">20015409</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Camilleri</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lasch</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>W</given-names></name>. <article-title>Irritable bowel syndrome: methods, mechanisms, and pathophysiology</article-title>. <source>The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. American journal of physiology Gastrointestinal and liver physiology</source>. <year>2012</year>; <volume>303</volume>:<fpage>G775</fpage>–<lpage>785</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpgi.00155.2012" xlink:type="simple">10.1152/ajpgi.00155.2012</ext-link></comment> <object-id pub-id-type="pmid">22837345</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lovell</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Ford</surname> <given-names>AC</given-names></name>. <article-title>Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis</article-title>. <source>Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association</source>. <year>2012</year>; <volume>10</volume>:<fpage>712</fpage>–<lpage>721</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grundmann</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Yoon</surname> <given-names>SL</given-names></name>. <article-title>Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners</article-title>. <source>Journal of gastroenterology and hepatology</source>. <year>2010</year>; <volume>25</volume>:<fpage>691</fpage>–<lpage>699</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1440-1746.2009.06120.x" xlink:type="simple">10.1111/j.1440-1746.2009.06120.x</ext-link></comment> <object-id pub-id-type="pmid">20074154</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gwee</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Bak</surname> <given-names>YT</given-names></name>, <name name-style="western"><surname>Ghoshal</surname> <given-names>UC</given-names></name>, <name name-style="western"><surname>Gonlachanvit</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>OY</given-names></name>, <name name-style="western"><surname>Fock</surname> <given-names>KM</given-names></name>, <etal>et al</etal>. <article-title>Asian consensus on irritable bowel syndrome</article-title>. <source>Journal of gastroenterology and hepatology</source>. <year>2010</year>; <volume>25</volume>:<fpage>1189</fpage>–<lpage>1205</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1440-1746.2010.06353.x" xlink:type="simple">10.1111/j.1440-1746.2010.06353.x</ext-link></comment> <object-id pub-id-type="pmid">20594245</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pan</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ke</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>X</given-names></name>. <article-title>An epidemiologic study of irritable bowel syndrome in Beijing—a stratified randomized study by clustering sampling</article-title>. <source>Zhonghua Liu Xing Bing Xue Za Zhi</source>. <year>2000</year>; <volume>21</volume>:<fpage>26</fpage>–<lpage>29</lpage>. <object-id pub-id-type="pmid">11860753</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiong</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>HX</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>WA</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>PJ</given-names></name>. <article-title>A population-based epidemiologic study of irritable bowel syndrome in Guangdong province</article-title>. <source>Zhonghua Yi Xue Za Zhi</source>. <year>2004</year>;<volume>84</volume>:<fpage>278</fpage>–<lpage>281</lpage>. <object-id pub-id-type="pmid">15059507</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Everhart</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Ruhl</surname> <given-names>CE</given-names></name>. <article-title>Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases</article-title>. <source>Gastroenterology</source>. <year>2009</year>; <volume>136</volume>:<fpage>376</fpage>–<lpage>386</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2008.12.015" xlink:type="simple">10.1053/j.gastro.2008.12.015</ext-link></comment> <object-id pub-id-type="pmid">19124023</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brandt</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Chey</surname> <given-names>WD</given-names></name>, <name name-style="western"><surname>Foxx-Orenstein</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Schiller</surname> <given-names>LR</given-names></name>, <name name-style="western"><surname>Schoenfeld</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Spiegel</surname> <given-names>BM</given-names></name>, <etal>et al</etal>. <article-title>An evidence-based position statement on the management of irritable bowel syndrome</article-title>. <source>The American journal of gastroenterology</source>. <year>2009</year>;<volume>104</volume> <issue>Suppl 1</issue>:<fpage>S1</fpage>–<lpage>35</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hussain</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Quigley</surname> <given-names>EM</given-names></name>. <article-title>Systematic review: Complementary and alternative medicine in the irritable bowel syndrome</article-title>. <source>Alimentary pharmacology &amp; therapeutics</source>. <year>2006</year>; <volume>23</volume>:<fpage>465</fpage>–<lpage>471</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>YX</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Grimsgaard</surname> <given-names>S</given-names></name>. <article-title>Herbal medicines for treatment of irritable bowel syndrome</article-title>. <source>The Cochrane database of systematic reviews</source>. <year>2006</year>: <fpage>Cd004116</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.CD004116.pub2" xlink:type="simple">10.1002/14651858.CD004116.pub2</ext-link></comment> <object-id pub-id-type="pmid">16437473</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>HX</given-names></name>. <article-title>Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: a systematic review</article-title>. <source>World journal of gastroenterology</source>. <year>2008</year>; <volume>14</volume>:<fpage>454</fpage>–<lpage>462</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3748/wjg.14.454" xlink:type="simple">10.3748/wjg.14.454</ext-link></comment> <object-id pub-id-type="pmid">18200670</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yuan</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>Y</given-names></name>. <article-title>Traditional Chinese medicine: an approach to scientific proof and clinical validation</article-title>. <source>Pharmacology &amp; Therapeutics</source>. <year>2000</year>;<volume>86</volume>(<issue>2</issue>): <fpage>191</fpage>–<lpage>198</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>Chinese Society of Digestive Diseases and Chinese Association of Chinese Medicine</collab>. <article-title>Consensus on the diagnosis and treatment of functional dyspepsia irritable bowel syndrome by Traditional Chinese Medicine</article-title>. <source>China J Trad Chin Med Pharm</source> <year>2010</year>; <volume>25</volume>:<fpage>1062</fpage>–<lpage>1065</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leung</surname> <given-names>WK</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>FK</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial</article-title>. <source>The American journal of gastroenterology</source>. <year>2006</year>;<volume>101</volume>:<fpage>1574</fpage>–<lpage>1580</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1572-0241.2006.00576.x" xlink:type="simple">10.1111/j.1572-0241.2006.00576.x</ext-link></comment> <object-id pub-id-type="pmid">16863563</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sung</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Leung</surname> <given-names>WK</given-names></name>, <name name-style="western"><surname>Ching</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Lao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome</article-title>. <source>Alimentary pharmacology &amp; therapeutics</source>. <year>2004</year>; <volume>20</volume>:<fpage>1205</fpage>–<lpage>1210</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials</article-title>. <source>PloS one</source>. <year>2015</year>;<volume>10</volume>:<fpage>e0122397</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0122397" xlink:type="simple">10.1371/journal.pone.0122397</ext-link></comment> <object-id pub-id-type="pmid">25853241</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>GY</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>JP</given-names></name>. <article-title>Syndrome differentiation in chinese herbal medicine for irritable bowel syndrome: a literature review of randomized trials</article-title>. <source>Evidence-based complementary and alternative medicine: eCAM</source>. <year>2013</year>;<volume>2013</volume>:<fpage>232147</fpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Drossman</surname> <given-names>DA</given-names></name>.<article-title>The functional gastrointestinal disorders and the Rome II process</article-title>. <source>Gut</source>, <year>1999</year>,<volume>45</volume> <issue>Suppl 2</issue>:<fpage>II 1</fpage>–<lpage>II 5</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Drossman</surname> <given-names>DA</given-names></name>.<article-title>The functional gastrointestinal disorders and the Rome III process</article-title>.<source>Gastroenterology</source>, <year>2006</year>, <volume>130</volume>(<issue>5</issue>):<fpage>1377</fpage>–<lpage>1390</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2006.03.008" xlink:type="simple">10.1053/j.gastro.2006.03.008</ext-link></comment> <object-id pub-id-type="pmid">16678553</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmulson</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Drossman</surname> <given-names>DA</given-names></name>. <article-title>What Is New in Rome IV</article-title>. <source>J Neurogastroenterol Motil</source>,<year>2017</year>; <volume>23</volume> (<issue>2</issue>): <fpage>151</fpage>–<lpage>163</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5056/jnm16214" xlink:type="simple">10.5056/jnm16214</ext-link></comment> <object-id pub-id-type="pmid">28274109</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref024"><label>24</label><mixed-citation publication-type="book" xlink:type="simple"><collab>National TCM Authority</collab>.<source>TCM Illness Diagnosis Effect Standard</source>. <publisher-loc>Nanjing</publisher-loc>:<publisher-name>Nanjing University Press</publisher-name>.<year>1994</year>:<fpage>11</fpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref025"><label>25</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Zheng</surname> <given-names>XY</given-names></name>. <chapter-title>Chinese herbal medicine new medicine clinical research guiding principle</chapter-title> [M]. <publisher-loc>Beijing</publisher-loc>: <publisher-name>China Medical Science Press</publisher-name>. <year>2002</year>:<fpage>124</fpage>–<lpage>129</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jadad</surname> <given-names>A. R.</given-names></name>, <name name-style="western"><surname>Moore</surname> <given-names>R. A.</given-names></name>, <name name-style="western"><surname>Carroll</surname> <given-names>D.</given-names></name> <etal>et al</etal>., “<article-title>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</article-title>”<source>Controlled Clinical Trials</source>. <year>1996</year>;<volume>17</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>. <object-id pub-id-type="pmid">8721797</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yue</surname> <given-names>C</given-names></name>1, <name name-style="western"><surname>Kang</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Pei</surname> <given-names>F</given-names></name>.<article-title>Comparison of Direct Anterior and Lateral Approaches in Total Hip Arthroplasty: A Systematic Review and Meta-Analysis (PRISMA)</article-title>.<source>Medicine (Baltimore)</source>.<year>2015</year>;<volume>94</volume>(<issue>50</issue>):<fpage>e2126</fpage>,1–10.</mixed-citation></ref>
<ref id="pone.0189491.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ (Clinical research ed)</source>. <year>2003</year>; <volume>327</volume>:<fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>.<article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source>. <year>1986</year>;<volume>7</volume>(<issue>3</issue>):<fpage>177</fpage>–<lpage>188</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>.<source>Biometrics</source> <year>1994</year>;<volume>50</volume>(<issue>4</issue>): <fpage>1088</fpage>–<lpage>10101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cai</surname> <given-names>W</given-names></name>. <article-title>Clinical Observation of Liver-Discharging and Stomach-Harmonizing Therapy for Constipation-Predominant Irritable Bowel Syndrome in 60 Cases</article-title>, <source>Shanghai Journal of Traditional Chinese Medicine</source>.<year>2005</year>,<volume>39</volume>(<issue>5</issue>):<fpage>14</fpage>–<lpage>15</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>XG</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>XY</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>WP</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>ZZ</given-names></name>, <name name-style="western"><surname>Qiu</surname> <given-names>XS</given-names></name>. <article-title>Clinical research on Yigi II recipe in treating Constipation-Predominant Irritable Bowel Syndrome of children</article-title>. <source>ShanDong Journal of Traditional Chinese Medical</source>.<year>2005</year>,<volume>24</volume>(<issue>9</issue>):<fpage>526</fpage>–<lpage>528</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>JH</given-names></name>. <article-title>Clinical Observation of Tonifying Qi, Strengthening Spleen and regulating Qi Therapy for Constipation-Predominant Irritable Bowel Syndrome in 85 Cases</article-title>. <source>Guangming Journal of Chinese Medicine</source>,<year>2006</year>,<volume>21</volume>(<issue>4</issue>):<fpage>34</fpage>–<lpage>35</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>CL</given-names></name>.<article-title>Treatment of Constipation-Predominant Irritable Bowel Syndrome by “Yangxue Tongfu Decoction” in 50 Cases</article-title>. <source>Jiangxi Journal of Traditional Chinese Medicine</source>,<year>2008</year>,<volume>39</volume>(<issue>3</issue>):<fpage>21</fpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>HY</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>YQ</given-names></name>. <article-title>A randomized controlled trial of Traditional Chinese Medicine compound granules with Regulating Qi and Moistening the Intestines for Constipation-Predominant Irritable Bowel Syndrome</article-title>. <source>Zhejiang Journal of Traditional Chinese Medicine</source>.<year>2011</year>,<volume>46</volume>(<issue>11</issue>):<fpage>788</fpage>–<lpage>789</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liao</surname> <given-names>J</given-names></name>,<name name-style="western"><surname>Xiong</surname> <given-names>J</given-names></name>. <article-title>A Clinical Observation of Sini Powder and Liumo Decoction for Constipation-Predominant Irritable Bowel Syndrome</article-title>. <source>Journal of Sichuan of Traditional Chinese Medicine</source>. <year>2011</year>,<volume>29</volume>(<issue>9</issue>): <fpage>59</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref037"><label>37</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Qian</surname> <given-names>CJ</given-names></name>. <source>The Clinical Study of Supplemented Fluid-increasing Decoction in Treating Syndrome of intestinal dryness due to Yin deficiency of Irritable Bowel Syndrome</source>[D]. <publisher-loc>Nanjing</publisher-loc>:<publisher-name>Nanjing Chinese Medical University</publisher-name>;<year>2011</year>.</mixed-citation></ref>
<ref id="pone.0189491.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ren</surname> <given-names>NX</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>DY</given-names></name>. <article-title>20 Cases of Constipation-Predominant Irritable Bowel Syndrome treated with therapy of Replenishing Qi to invigorate the Spleen and ventilating the Lung</article-title>. <source>Chinese Medicine Modern Distance Education of China</source>.<year>2013</year>,<volume>11</volume>(<issue>8</issue>):<fpage>20</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>XP</given-names></name>, <article-title>Clinical Research of Constipation-Predominant Irritable Bowel Syndrome treated with Guipi Decoction and Xiaoyao Powder</article-title>. <source>China Journal of Chinese Medicine</source>.<year>2014</year>,<volume>29</volume>(<issue>11</issue>): <fpage>1667</fpage>–<lpage>1668</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref040"><label>40</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>FD</given-names></name>. <source>Clinical Study of the San Zang Tiao He Run Chang Decoction in Treating Irritable Bowel Syndrome with Constipation</source>[D]. <publisher-loc>Zhejiang</publisher-loc>:<publisher-name>Zhejiang University of Chinese Medical</publisher-name>; <year>2015</year>.</mixed-citation></ref>
<ref id="pone.0189491.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>ZY</given-names></name>. <article-title>Clinical Observation of TCM Syndrome Differentiation Therapy for Constipation- Predominant Irritable Bowel Syndrome in 60 Cases</article-title>. <source>China Practical Medical</source>. <year>2016</year>, <volume>11</volume>(<issue>21</issue>):<fpage>37</fpage>–<lpage>38</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>H</given-names></name>. <article-title>Traditional Chinese medicine decoction and Fried condition survey analysis</article-title>. <source>China Pharmacist</source>. <year>2009</year>;<volume>9</volume>: <fpage>1360</fpage>–<lpage>1362</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stanghellini</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Tosetti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Barbara</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>De Giorgio</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Cogliandro</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Cogliandro</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Corinaldesi</surname> <given-names>R</given-names></name>. <article-title>Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome</article-title>. <source>The American journal of gastroenterology</source>. <year>2002</year>; <volume>97</volume>:<fpage>2738</fpage>–<lpage>2743</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1572-0241.2002.07062.x" xlink:type="simple">10.1111/j.1572-0241.2002.07062.x</ext-link></comment> <object-id pub-id-type="pmid">12425541</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tillisch</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Labus</surname> <given-names>JS</given-names></name>. <article-title>Advances in imaging the brain-gut axis: functional gastrointestinal disorders</article-title>. <source>Gastroenterology</source>. <year>2011</year>;<volume>140</volume>:<fpage>407</fpage>–<lpage>411</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2010.12.014" xlink:type="simple">10.1053/j.gastro.2010.12.014</ext-link></comment> <object-id pub-id-type="pmid">21167161</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tillisch</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mayer</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Labus</surname> <given-names>JS</given-names></name>. <article-title>Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome</article-title>. <source>Gastroenterology</source>. <year>2011</year>; <volume>140</volume>:<fpage>91</fpage>–<lpage>100</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2010.07.053" xlink:type="simple">10.1053/j.gastro.2010.07.053</ext-link></comment> <object-id pub-id-type="pmid">20696168</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barbara</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Zecchi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Barbaro</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Cremon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bellacosa</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Marcellini</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome</article-title>. <source>Journal of clinical gastroenterology</source>. <year>2012</year>;<volume>46</volume> <issue>Suppl</issue>:<fpage>S52</fpage>–<lpage>55</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Enck</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Aziz</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Barbara</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Farmer</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Fukudo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mayer</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Niesler</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Quigley</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Rajilic-Stojanovic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schemann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schwille-Kiuntke</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Simren</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zipfel</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Spiller</surname> <given-names>RC</given-names></name>. <article-title>Irritable bowel syndrome</article-title>. <source>Nature reviews Disease primers</source>. <year>2016</year>;<volume>2</volume>:<fpage>16014</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrdp.2016.14" xlink:type="simple">10.1038/nrdp.2016.14</ext-link></comment> <object-id pub-id-type="pmid">27159638</object-id></mixed-citation></ref>
<ref id="pone.0189491.ref048"><label>48</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Qiu</surname> <given-names>B</given-names></name>. <source>Experimental Study on Ma Zhi Jiang Zhuo Improving 5-HT of Intestinal Tissue in the Rat Model of Constipation-predominant Irritable Bowel Syndrome</source>[D].<publisher-loc>Hebei</publisher-loc>: <publisher-name>HeBei Medical University</publisher-name>; <year>2013</year>.</mixed-citation></ref>
<ref id="pone.0189491.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname> <given-names>ZY</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Dai</surname> <given-names>HM</given-names></name>, <etal>et al</etal>.<article-title>Effect of Maziren Pills on the content of 5-HT in intestinal mucosa in rats with constipation-type irritable bowel syndrome</article-title>. <source>Modern Journal of Integrated Traditional Chinese and Western Medicine</source>.<year>2014</year>,<volume>23</volume>(<issue>4</issue>): <fpage>343</fpage>–<lpage>346</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref050"><label>50</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Fu</surname> <given-names>F</given-names></name>.<source>The Clinical Study of Maren Pills flavored in treating constipation predominant Irritable Bowel Syndrome of children</source>[D]. <publisher-loc>Fujian</publisher-loc>: <publisher-name>Fujian university of traditional Chinese medicine</publisher-name>; <year>2015</year>.</mixed-citation></ref>
<ref id="pone.0189491.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>YY</given-names></name>,<name name-style="western"><surname>Ai</surname> <given-names>ZF</given-names></name>,<name name-style="western"><surname>Zhu</surname> <given-names>LJ</given-names></name>. <article-title>Effect of Liver-Discharging, Qi-Regulating and Intestines-Moistening Therapy on gastrointestinal hormone in patients with Constipation-Predominant Irritable Bowel Syndrome</article-title>. <source>LiShiZhen Medicine and Materia Medical Research</source>. <year>2014</year>,(<issue>09</issue>):<fpage>2192</fpage>–<lpage>2194</lpage>.</mixed-citation></ref>
<ref id="pone.0189491.ref052"><label>52</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>XY</given-names></name>, <source>The Clinical Study and mechanism of the Kuanzhongjieyutang in treating constipation predominant Irritable Bowel Syndrome(Liver–Qi stagnation)</source>[D].<publisher-loc>ShanDong</publisher-loc>:<publisher-name>ShanDong University of Traditional Chinese Medical</publisher-name>;<year>2013</year>.</mixed-citation></ref>
<ref id="pone.0189491.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>SW</given-names></name>,<name name-style="western"><surname>Liu</surname> <given-names>XJ</given-names></name>,<name name-style="western"><surname>Zhen</surname> <given-names>HL</given-names></name>, <etal>et al</etal>. <article-title>Efficacy of Shanzha Xiaozhi Capsule on irritable bowel syndrome and its’ influence on motilin and endothelin</article-title>.<source>Zhejiang Journal of traditional Chinese medicine</source>. <year>2016</year>, (<issue>11</issue>): <fpage>815</fpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>